Loading clinical trials...
Loading clinical trials...
A Phase 3 Substudy to Evaluate Executive Function in Adults With Phenylketonuria Who Are Participating in the Phase 3 Study, 165-302
Conditions
Interventions
Administration of CANTAB and Subject Global Assessment
Locations
4
United States
University of Kentucky Medical Center
Lexington, Kentucky, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Oregon Health and Science University
Portland, Oregon, United States
Start Date
August 5, 2015
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
June 4, 2020
NCT06560736
NCT06332807
NCT06780332
NCT05270837
NCT04480567
NCT07241234
Lead Sponsor
BioMarin Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions